Angiotensin-Converting Enzyme Inhibitory Peptide Derived from Ultrafine Lycium barbarum Pomace Powder: In Vitro and In Silico Analysis
Journal of Agricultural and Food Chemistry · 2025
DOI: 10.1021/acs.jafc.5c01994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2025. Verfasst von Yuxin Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Ningxia Medical University, Yinchuan 750004, China. Hauptthemen laut MEDLINE: Lycium, Angiotensin-Converting Enzyme Inhibitors, Peptides, Drugs, Chinese Herbal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Program of Ningxia, Natural Science Foundation of Ningxia Province.
Abstract (Originalsprache)
This study aimed to identify the sequence and assess the stability of angiotensin-converting enzyme (ACE) inhibitory peptides derived from ultrafine Lycium barbarum pomace powder (u-LPP), while network pharmacology analysis was employed to explore potential mechanisms for heart failure with preserved ejection fraction (HFpEF) improvement. The peptides identified by LC–MS/MS were GPFN, LGGP, AGLP, and TAFP, among which GPFN had the highest activity (IC50 of 324.44 ± 8.93 μM). GPFN exhibits gastrointestinal enzyme hydrolysis resistance. Furthermore, after 2 h of incubation, GPFN could permeate Caco-2 cell monolayers through the paracellular route by passive diffusion. Molecular docking revealed that GPFN could stably bind to ACE (binding energy of −8.88 kcal/mol). Molecular dynamics (MD) simulation indicated that the ACE–GPFN complex had good stability. Network pharmacological analysis and molecular docking demonstrated strong interactions between GPFN and key targets, such as CASP3, MMP9, SRC, APP, ACE, and MMP2. GPFN might have the potential activity to improve HFpEF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Ningxia Medical University, Yinchuan 750004, China.
- Ningxia Key Laboratory of Environmental Factors and Chronic Disease Control, Yinchuan 750004, China.
- School of Medical Information and Engineering, Ningxia Medical University, Yinchuan 750004, China.
ORCID-Profile: Jianjun Yang
Förderung
- Key Research and Development Program of Ningxia
- Natural Science Foundation of Ningxia Province
Zitieren
APA
Zhao, Y., Cui, H., Lin, H., Gong, W., Li, N., & Yang, J. (2025). Angiotensin-Converting Enzyme Inhibitory Peptide Derived from Ultrafine Lycium barbarum Pomace Powder: In Vitro and In Silico Analysis. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c01994
Vancouver
Zhao Y, Cui H, Lin H, Gong W, Li N, Yang J. Angiotensin-Converting Enzyme Inhibitory Peptide Derived from Ultrafine Lycium barbarum Pomace Powder: In Vitro and In Silico Analysis. Journal of Agricultural and Food Chemistry. 2025. doi:10.1021/acs.jafc.5c01994
BibTeX
@article{Zhao2025,
author = {Zhao, Yuxin and Cui, Huimin and Lin, Hong and Gong, Wei and Li, Na and Yang, Jianjun},
title = {Angiotensin-Converting Enzyme Inhibitory Peptide Derived from Ultrafine Lycium barbarum Pomace Powder: In Vitro and In Silico Analysis},
journal = {Journal of Agricultural and Food Chemistry},
year = {2025},
doi = {10.1021/acs.jafc.5c01994}
}
EUVIMED